Wells Fargo’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
20,192
+3,196
| +19% | +$31.9K | ﹤0.01% | 4380 |
|
|
2025
Q1 | $101K | Buy |
16,996
+352
| +2% | +$2.1K | ﹤0.01% | 4649 |
|
|
2024
Q4 | $128K | Buy |
16,644
+2,402
| +17% | +$18.4K | ﹤0.01% | 4575 |
|
|
2024
Q3 | $145K | Buy |
14,242
+2,811
| +25% | +$28.7K | ﹤0.01% | 4396 |
|
|
2024
Q2 | $170K | Buy |
11,431
+1,400
| +14% | +$20.8K | ﹤0.01% | 4268 |
|
|
2024
Q1 | $137K | Buy |
10,031
+2,358
| +31% | +$32.2K | ﹤0.01% | 4339 |
|
|
2023
Q4 | $84K | Sell |
7,673
-13,940
| -64% | -$153K | ﹤0.01% | 4602 |
|
|
2023
Q3 | $237K | Sell |
21,613
-3,748
| -15% | -$41K | ﹤0.01% | 3950 |
|
|
2023
Q2 | $336K | Buy |
25,361
+793
| +3% | +$10.5K | ﹤0.01% | 4019 |
|
|
2023
Q1 | $334K | Buy |
24,568
+23,855
| +3,346% | +$325K | ﹤0.01% | 3861 |
|
|
2022
Q4 | $13.9K | Sell |
713
-1,511
| -68% | -$29.5K | ﹤0.01% | 5096 |
|
|
2022
Q3 | $42K | Sell |
2,224
-221
| -9% | -$4.17K | ﹤0.01% | 4724 |
|
|
2022
Q2 | $51K | Sell |
2,445
-357
| -13% | -$7.45K | ﹤0.01% | 4737 |
|
|
2022
Q1 | $89K | Sell |
2,802
-5,555
| -66% | -$176K | ﹤0.01% | 5062 |
|
|
2021
Q4 | $390K | Sell |
8,357
-51,544
| -86% | -$2.41M | ﹤0.01% | 4534 |
|
|
2021
Q3 | $1.62M | Buy |
59,901
+59,685
| +27,632% | +$1.61M | ﹤0.01% | 3661 |
|
|
2021
Q2 | $5K | Sell |
216
-1,658
| -88% | -$38.4K | ﹤0.01% | 6001 |
|
|
2021
Q1 | $64K | Sell |
1,874
-5,937
| -76% | -$203K | ﹤0.01% | 5351 |
|
|
2020
Q4 | $264K | Sell |
7,811
-92
| -1% | -$3.11K | ﹤0.01% | 4815 |
|
|
2020
Q3 | $195K | Buy |
+7,903
| New | +$195K | ﹤0.01% | 4807 |
|